Demitrios Vynios

6PUBLICATIONS
13CO-AUTHORS
Nanotoxicology, health and safetyPredictive and prognostic markersOrthopticsMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 26, 2026
A Two-Phase Translational Framework for Personalized Ozone Therapy: From Baseline Clinical Redox Screening to Individualized Ex Vivo Concentration Selection.

|May 27, 2026
Integrative Survival Prediction in Breast Cancer Using Extracellular Matrix Protease Transcript Signatures and Clinical Variables: A Machine Learning Approach.

|May 20, 2026
Clinical analysis of demographic variables and factors contributing to outcomes in peripheral neuropathy secondary to lumbar spinal disorders following ozone therapy: A retrospective study.

|Sep 02, 2022
Steviol glycosides affect functional properties and macromolecular expression of breast cancer cells.

Christos Velesiotis, Marinos Kanellakis, Demitrios H Vynios

|Apr 30, 2021
Lumican Inhibits In Vivo Melanoma Metastasis by Altering Matrix-Effectors and Invadopodia Markers.

Konstantina Karamanou, Marco Franchi, Isabelle Proult

|Mar 12, 2020
Evaluation of lumican effects on morphology of invading breast cancer cells, expression of integrins and downstream signaling.

Konstantina Karamanou, Marco Franchi, Maurizio Onisto

Pageof 1

Frequent Collaborators

2 joint publications

Marco Franchi

2 joint publications

Ioannis Iliakis

1 joint publications

Konstantina Karamanou

1 joint publications

Maurizio Onisto